Get Bold in Your Inbox

Multiple sclerosis, often referred to as MS, affects 2.3 million people throughout the world. There is often an association between  this progressive neurologic disorder and significant disability, as well as expense.  The lifetime costs for an individual with MS exceeds $4 million. Treatments are available for the disease, but a cure for MS remains out of reach to date. However, companies like ImStem Biotechnologies are investigating new areas of research to hopefully change that. Their research with stem cell treatments looks quite promising.

stem cell treatment, stem cell in a tube
Is cure for multiple sclerosis through stem cell treatment finally on the horizon?

Why a Cure for MS is So Challenging

Multiple sclerosis is an autoimmune disease.  It affects the brain and spinal cord. Antibodies attack the myelin coating on these nerves, which can result in a variety of problems. Paralysis, numbness, incoordination, double vision, and blindness are just a few of the more severe e effects.

Ideally, a cure for MS would target the issue that is causing the autoimmune reaction. But the exact cause of MS remains unknown. Therefore, therapies available today seek to reduce the inflammation caused by MS and promote nerve repair. Until the exact cause is known, developing an actual cure for MS will be difficult.

stem cell treatment, dr. xiaofang wang quoted
MS treatment with no side effects–hope for millions around the world.

ImStem Biotechnologies Unique Approach

Though a cure for MS does not exist, ImStem Biotechnologies is taking a different approach in treating the disorder. Stem cell research looks promising for several reasons. First, stem cells can help regulate the immune system by reducing its level of activity. For autoimmune diseases, this is a good thing.

Stem cell treatments also help nerves repair and regenerate tissue damage by the autoimmune process.  Also, because stem cell treatments introduce human cells and not drugs, side effects are not expected. This is why ImStem Biotechnologies is bold on its stem cell treatments in advancing a cure for MS.

stem cell treatment, thomas lane quoted
Stem cell treatment, possibly a wonderful beginning for MS patients.

How Stem Cell Treatment Works in MS

In essence, stem cell treatments provide cells that can develop into a number of different tissues. ImStem Biotechnologies use mesenchymal stem cells, which means these cells can develop into a variety of different tissues. As a result, stem cell treatments have the potential to help individuals with MS improve.

Additionally, the stem cell treatments developed by ImStem Biotechnologies suppress the immune system and have very low levels of inflammation. In seeking a cure for MS, this is also a desirable feature of the therapy. ImStem Biotechnologies believes this is why their stem cell treatments show effective results in animal research studies.

cure for ms, dr xiaofang wang in a lab gown looking into a microscope
Not just a cure for MS, stem cell also gives hope to other autoimmune diseases.

ImStem Biotechnologies Focus on Human Embryo Stem Cells

Different types of stem cell treatments exist. Some stem cells are derived from the bone marrow (BM). However,  ImStem Biotechnologies develop their stem cell treatments from human embryos (hES). This makes a difference because hES stem cell treatments promote healing in Multiple Sclerosis and reduce inflammation. 

BM stem cells do not seem to have this effect. In addition, hES stem cells can cross into the brain and spinal cord. This allows these stem cells to potentially carry other treatments into the central nervous system where MS inflammation occurs.

Moving Closer to a Cure for Multiple Sclerosis

ImStem Biotechnologies was founded in 2012 as a spinoff of the University of Connecticut Stem Core Lab. The advancements that ImStem Biotechnologies are making toward a cure for MS are in part due to the company’s support.

ImStem Biotechnologies enjoys over $1.1 million in grant funding and private capital funding. This facilitated ImStem Biotechnologies’ success in attaining a patent in 2017 for its stem cell treatments.

At this point in time, ImStem Biotechnologies plans to launch Phase I trials soon. If effective, the company stands to benefit greatly from its proprietary stem cell treatment manufacturing process. Their methods produce 200 times more yield in stem cells with less processing time and 75% less cost. Though this may not be a cure for MS, stem cell treatments offer great potential for better MS care. This is great news for MS sufferers.

John Miles

    

John R. Miles
EVP & Associate Publisher

John R. Miles is Executive Vice President of Business Development and Associate Publisher of Bold Business. He is a sought-after motivational speaker and writer. He brings visionary leadership style and talent as a Navy Veteran and an internationally experienced CEO, COO, and Fortune 50 CIO across a multitude of industries. Miles is also an operating partner at the Virgo Investment Group where he is responsible for identifying and pursuing new investments while supporting existing portfolio companies with operational expertise. He is active on Linkedin and  Twitter and published in a variety of media. Miles graduated with honors from the U.S. Naval Academy where he was a varsity athlete.

black and white logo of Bold Wire for Bold Business
The Bold Wire delivers our latest global news, exclusive top stories, industry leading infographics, powerful interviews and bold opinions. It is a free weekly newsletter.